sgpressreleases
Monday, 16 November 2026
TAIWAN’S FUBON INSURANCE CREDIT RATINGS AFFIRMED, OUTLOOK STABLE
The credit ratings (ratings) reflect Fubon Insurance’s very strong balance sheet strength, adequate operating performance, favourable business profile and appropriate enterprise risk management, according to AM Best.
The credit rating agency upgraded its assessment of Fubon Insurance's balance sheet strength to very strong from strong, citing improved risk-adjusted capitalisation, as measured by Best's Capital Adequacy Ratio.
In a statement, AM Best said the company's consolidated capital and surplus grew at a double-digit rate in 2025 and continued to increase in the first half of 2026, reaching TWD39.5 billion (TWD100 = RM12.40)
The improvement was supported by the retention of positive underwriting and investment results, while pandemic-related reinsurance recoverables were fully settled in late 2025. Uncertainty surrounding deferred tax assets arising from pandemic-related insurance losses had also largely eased, although the company's risk-adjusted capitalisation remained below pre-pandemic levels.
Other supporting factors include a diversified investment portfolio focused on low-risk fixed-income securities, comprehensive reinsurance arrangements, adequate liquidity and long-term capital support from its parent, Fubon Financial Holding Co Ltd.
Fubon Insurance reported a net profit of TWD7.4 billion in 2025, while gross premiums written grew at a mid-single-digit rate, mainly driven by expansion in its motor and engineering businesses. Its combined ratio improved to 88.5 per cent, supported by favourable claims experience and a lower expense ratio.
The company also recorded a net profit of TWD5.7 billion in the first half of 2026, attributed to favourable underwriting performance and investment gains from capital appreciation. Fubon Insurance maintained its leading position in Taiwan's non-life insurance market, with a 24.6 per cent share of direct premiums written in the first nine months of 2026.
-- BERNAMA
SBC Medical Announces Capital and Business Alliance with NeuroBrain Dynamics to Advance Clinic Profitability Through Medical AI
IRVINE, Calif., Nov 16 (Bernama-BUSINESS WIRE) -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, today announced a strategic capital and business alliance agreement with NeuroBrain Dynamics Inc. (“NBD”), a Taipei-based company dedicated to enterprise generative AI solutions. As part of the agreement executed on November 13, 2026, SBC Medical has made a minority equity investment in NBD.
Through this alliance, SBC Medical plans to introduce two complementary suites of generative AI solutions across its network of 287 clinics in Japan and overseas*: “revenue-growth AI,” to elevate average revenue per visit and customer retention through personalized customer guidance, and “cost-reduction AI,” to streamline medical documentation, staff scheduling, and promotional workflows. These initiatives are designed to improve per-clinic profitability.
Furthermore, SBC Medical has secured priority sales rights for NBD’s existing products in Japan and South Korea. The Company plans to offer these proven solutions to external medical institutions, establishing a high-margin business-to-business (B2B) revenue stream and accelerating its expansion into broader Asian markets alongside NBD.
Key Points of the Alliance
- Accelerating Top-Line Revenue Growth: Utilizing NBD’s enterprise AI platform “Argon,” the companies will develop and deploy an AI-powered concierge guidance tool and a history-based predictive recommendation feature for SBC Medical’s “MySBC” booking system to maximize customer lifetime value (LTV).
- Optimizing Operational Margin: Generative AI will assist with routine clinical documentation, optimize staff scheduling, and generate compliant marketing materials (with final review by physicians and staff). With reduced administrative burdens, physicians and clinic staff can redirect critical hours toward high-value medical care and customer service.
- Establishing a Standardized Foundation for Scale: The jointly developed AI platform will serve as the standardized operating foundation for SBC Medical’s next growth phase, driving rapid clinic deployments across Japan via organic openings and M&A. The solutions will be built primarily on a sovereign Large Language Model (LLM) platform designed to strengthen data privacy and compliance.
With a footprint of 287 clinics, minor operational efficiencies could yield substantial margin improvements across the entire Group. The alliance focuses on the development and deployment of six core solutions.
Revenue Growth & Retention
1. AI Concierge Guidance Support Tool: Analyzes each customer’s visit and treatment history and instantly displays on the concierge’s screen the information needed to assist the customer. The tool helps reduce variations in the quality of guidance arising from differences in staff experience, enabling customers to receive accurate information promptly and supporting higher average revenue per visit for the Company across all 287 clinics. (Note: All clinical decisions remain strictly under physician discretion.)
2. History-Based Recommendation Feature for “MySBC”: Delivers personalized, non-intrusive follow-up suggestions within the MySBC booking system based on each customer’s usage history, driving recurring appointments without additional user acquisition costs.
Solutions 1 and 2 will be co-developed based on NBD’s existing AI platform, Argon.
Productivity & Margin Improvement
3. AI-Assisted Electronic Medical Records (EMR): Converts patient-doctor consultation dialogue into structured SOAP (Subjective, Objective, Assessment, Plan) formatted drafts using speech recognition. This expands physician daily patient capacity while minimizing clerical burnout. Verification will begin in orthopedics, with accuracy testing scheduled for completion via a proof of concept (PoC) by year-end 2026.
4. AI Smart Shift Scheduling: Automates complex shift scheduling for physicians and nurses by mapping customer demand against labor laws and regulations, clinic rules, and the procedures each physician is able to perform. This eliminates manual management overhead and optimizes labor cost efficiency during peak clinic hours.
5. Clinic Promotion Planner (CPP): Automatically generates compliant promotional images for social media based on the specified treatments, services, and key messages, with built-in automated checks against internal guidelines, drastically reducing outsourcing dependencies and marketing cycle times.
Infrastructure and Security
6. Sovereign LLM and “Bromine” Security Monitoring: The solutions are built primarily on SBC Medical’s secure, sovereign LLM infrastructure to protect customer confidentiality. NBD’s proprietary security product, Bromine, will continuously monitor AI inputs and detect potential data leakage risks, providing enterprise-grade governance.
Synergies and Partner Selection
The deployment architecture enables an asset-light international expansion model. Local operating partners across Asia will provide the physical capital and operational management, while SBC Medical and NBD deliver the core technological foundation and clinical workflows.
Founded in Taiwan in June 2024, NBD has successfully deployed enterprise AI systems across more than 100 companies in the Asia-Pacific region, including multi-site operators such as a major convenience store chain, mass retailers, and railway and airline companies. NBD’s rapid operational scaling, expanding to seven strategic hub cities (Taipei, Hong Kong, Bangkok, Manila, Ho Chi Minh City, Kuala Lumpur, and Jakarta) within approximately two years, supports its capability to anchor SBC Medical’s international growth roadmap.
Outlook
The Company will systematically validate each AI module, with rollout for the AI Concierge Guidance Support Tool, the MySBC history-based recommendation feature, and CPP scheduled across the clinic network starting mid-2027. Concurrently, the Company will launch commercial outreach to market these systems to third-party medical institutions, while advancing B2B expansion in Asia.
Comments
Yoshiyuki Aikawa, CEO, SBC Medical Group Holdings Incorporated
“This alliance represents the next structural evolution of our MSO platform. Across a 287-clinic network, even micro efficiencies scale into significant potential earnings power. By blending SBC Medical’s deep, on-the-ground operational data with NeuroBrain Dynamics’ proven enterprise AI execution, we are positioning our business to achieve improved operating leverage while delivering exceptional value to our customers, clinic partners, and shareholders.”
Jeff Chuang, Chairman and CEO, NeuroBrain Dynamics Inc.
“We are truly honored to enter into this capital and business alliance with SBC Medical. Since our founding, NBD has built a distinctive ‘AI VDE (value delivery)’ culture that brings together forward deployed engineers (FDE), our research and development (R&D) team, and finance, and we have pursued AI implementation that delivers tangible value and ROI to businesses. The healthcare industry, where AI adoption is now gaining real momentum, is the field in which the reliability and effectiveness of AI are tested most rigorously. With our proprietary AI platforms Argon and Bromine at the core, we will work with SBC Medical to build medical AI solutions that achieve both safety and profitability, and bring them to Japan, South Korea, and markets across Asia.”
Overview of the Capital and Business Alliance
Partner: NeuroBrain Dynamics Inc. (創智動能股份有限公司)
Agreement date: November 13, 2026
Scope of the business alliance: Joint development of AI solutions for the SBC Medical Group; collaboration on deployment in Japan and South Korea; priority sales rights to distribute NBD’s existing products (including Bromine and Argon) in Japan and South Korea; and exclusive use of the jointly developed solutions in those regions
Capital alliance: Minority equity investment in NBD by SBC Medical
About NeuroBrain Dynamics Inc.
Company name: NeuroBrain Dynamics Inc. (創智動能股份有限公司)
Founded: June 2024
Location: 9F., No. 23, Sec. 1, Bade Rd., Zhongzheng Dist., Taipei City 100410, Taiwan
Representative: Jeff Chuang, Chairman
Business: AI implementation consulting and development for enterprises; provision of AI SaaS/PaaS
Website: https://nbd-ai.com/
| *As of the end of July 2026. |
| Note: The investment amount, shareholding ratio, and other details have not been disclosed. |
| Note: The initiatives under this alliance are based on current plans and are subject to change. |
About SBC Medical Group Holdings Incorporated
SBC Medical is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, hair loss treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose “Contributing to the well-being of people around the world through medical innovation,” SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.
For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company’s beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company’s control. These forward-looking statements reflect the Company’s current views with respect to, among other things, the Company’s plans and strategies for service expansion; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” “targets” or “hopes” or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management’s current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading “Risk Factors” and elsewhere in the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), which are accessible on the SEC’s website at www.sec.gov.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20261113869539/en/
Contact
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp
Source : SBC Medical Group Holdings Incorporated
Friday, 13 November 2026
AM BEST AFFIRMS MARBLE RE’S ‘EXCELLENT’ RATINGS, OUTLOOK STABLE
The outlook of these credit ratings (ratings) is stable, reflecting Marble Re’s strong balance sheet, strong operating performance, neutral business profile and appropriate enterprise risk management, AM Best said in a statement.
Marble Re’s risk-adjusted capitalisation is assessed at the strongest level and is expected to remain there, supported by a revised dividend policy that allows it to build capital, despite higher underwriting risks from business growth.
Its investment risk is minimal, with a portfolio made up of cash and short-term deposits, while credit risks from its moderately high reliance on reinsurance are mitigated by a high-quality and well-diversified reinsurance panel.
The company has recorded a five-year average combined ratio of 50 per cent from 2021 to 2025. Its premium income rose moderately in the financial year ended March 31, 2026, driven by growth in its captive business and the start of third-party business.
As a single-parent captive, Marble Re mainly insures risks within the Marubeni group, with marine cargo insurance remaining its main focus in the medium term. AM Best said Marble Re is well integrated with the Marubeni group in risk management, corporate governance and internal controls.
AM Best said the ratings could be lowered if Marble Re’s operating performance deviates materially from its business plan or if Marubeni’s credit profile deteriorates significantly, while an upgrade is unlikely in the medium term.
-- BERNAMA
ADDING MULTIMEDIA &Truth Launches &Atlas, Mapping the Global Mission to Provably Verify All Software
PALO ALTO, Calif., & SINGAPORE, Nov 13 (Bernama-BUSINESS WIRE) -- &Truth, a public benefit corporation building the universal verification machine for code, today unveiled &Atlas, an interactive map of over 100 million lines of open-source C software spanning more than 3,000 foundational codebases. &Atlas makes visible an unprecedented ambition: to mathematically verify all critical software in the AI era, beginning with C and expanding across languages and systems.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261112661845/en/
C code underpins operating systems, browsers, databases, networking, and other essential infrastructure. Much of it has been in use for decades, and vulnerabilities can have consequences far beyond a single application. As AI accelerates both software development and cyberattacks, the need to prove what code can and cannot do is increasingly urgent.
Through &Atlas, anyone can explore the map of open-source C codebases and zoom into individual projects and their dependencies. They can see what has been analyzed, what has been mathematically verified, and what remains. &Truth’s mapping algorithms bring code, dependencies, and verification results together in an interactive view of coverage, progress, and discovered bugs. The map reveals the scale of the challenge, without suggesting that the entire ecosystem is already secure.
From Mapping Code to Proving Its Safety
&Truth’s verification engine uses formal specifications and mathematical proofs to establish that code satisfies precisely stated properties, under explicit assumptions. Starting with memory safety and the absence of undefined behavior, the company is scaling toward increasingly comprehensive functional correctness. Proofs will be independently checkable using Lean, rather than requiring trust in &Truth’s assertions.
&Truth has already mathematically verified more than 100,000 lines of C code and uncovered numerous real-world defects. In recent weeks alone, the &Truth verification engine has verified thousands of lines per day. The company’s advances in scalable architecture and proprietary proof automation are driving accelerating gains in speed, efficiency, and autonomy.
Designed to scale with computing power, &Truth is advancing toward increasingly rapid, automated verification of complex software. As proof generation accelerates, the primary bottlenecks are increasingly shifting toward defect discovery, remediation, and extending verification to harder systems. This marks a significant step toward industrial-scale verification.
“Formal verification has traditionally required extraordinary expert effort,” explains Clark Barrett, Co-Founder and Co-CEO of &Truth. “We’re building the automation, specifications, and scalable architecture to verify entire software ecosystems, not just isolated programs. &Atlas makes both our progress and the immense challenge, including its complex interdependencies, visible to the world.”
Beyond Finding Bugs: Proving They Cannot Recur
&Truth has begun reaching out to maintainers and affected stakeholders through coordinated vulnerability disclosure and is working with them on remediation, without publicly exposing unresolved security issues. The goal is to fix defects and prove that corrected code satisfies specified safety properties, thereby eradicating entire classes of errors and vulnerabilities.
Initially read-only, &Atlas lets developers, open-source maintainers, and formal-methods researchers examine codebases, coverage, and specifications. &Truth plans to expand community collaboration, including by open-sourcing semantics, specifications, and proofs for verified code. The roadmap also includes moving beyond C to languages like Rust, Java, Go, C++, and Verilog and moving from open-source to enterprise software.
The Science of Specification
&Atlas shows the scale of the verification challenge, but mapping the world’s software is only the beginning. To mathematically verify it, we must first define precisely what the code is supposed to do. A proof is only as meaningful as the specification behind it. &Truth is advancing the “science of specification”: translating human intent into rigorous mathematical requirements, from memory safety to security and privacy to full functional correctness. Its modular architecture is designed to scale these specifications and their proofs across complex, interconnected software systems.
“The hardest part is not always proving that software meets a specification, but ensuring the specification captures what people intend,” says Ilya Sergey, Co-Founder and Chief Science Officer of &Truth. “A mathematically correct proof of the wrong requirement can create false confidence. Advancing the science of specification is essential to verifying software at scale. &Atlas makes both our progress and the challenge visible.”
Turning the Whole Map Green
&Atlas turns a vast technical challenge into a visible, measurable global endeavor: beginning with open-source C, expanding across languages and systems, and ultimately making mathematical proof foundational to the security of all critical software.
“The world depends on code most people never see,” states Chris Hsu, Co-Founder, Co-CEO, and Executive Chairman of &Truth. “Finding bugs is just the beginning. Our goal is to fix them, properly coordinate reporting, and mathematically prove that entire classes of failures will never recur in the code we verify. &Atlas makes our progress measurable. We invite the world to explore the map, join the mission, and help turn the whole map green.”
Explore &Atlas at atlas.andtruth.com.
ABOUT &TRUTH
&Truth is a public benefit corporation building the universal verification machine for code. We’re establishing an open, independently checkable standard for provably safe software, proving that legacy and AI-generated code meets precise requirements. Founded in 2026 and based in Palo Alto and Singapore, &Truth is committed to ensuring AI develops safely for humanity.
Interested in verifying your critical code? Joining the &Truth mission? Learn more and contact us at andTruth.com.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20261112661845/en/
Contact
Media and General Contact
Laura Weisman, Director of Communications, &Truth
laura@andtruth.com
PR Agency Contact
ASTRSK PR
andtruth@astrskpr.com
Source : &Truth
Thursday, 12 November 2026
TOKYO’S MON TAKANAWA TO HOST LONDON SOUND EXHIBITION
![]() |
| Key visual for “Feel the Sound” |
KUALA LUMPUR, Nov 12 (Bernama) -- The immersive sound exhibition ‘Feel the Sound’, first staged at London’s Barbican Centre, will make its Japan debut at MoN Takanawa: The Museum of Narratives in Tokyo from Nov 20 to March 22, 2027.
The exhibition, part of the new museum’s opening programme produced with the Barbican Centre, features installations combining sound, vibration, music and technology that let visitors feel sound with their whole body rather than only hear it.
According to the museum in a statement, the exhibition is curated by Luke Kemp, who will lead guided tours during a media preview on Nov 19.
It is co-produced by MoN Takanawa and supported by the British Council, with details of the participating artists, main installations and ticket prices to be announced later.
MoN Takanawa, in Tokyo’s Minato ward, is an experimental museum covering fields from traditional Japanese culture to manga, music and space. Its spiral, greenery-covered building was designed by Kengo Kuma & Associates.
The museum is operated by the East Japan Railway Foundation for Cultural Innovations.
-- BERNAMA
Axi joins Babypips as an advertising partner through its Trusted Partner programme
The arrangement gives Axi an opportunity to introduce its trading services to Babypips’ established global audience through its advertising platform
SYDNEY, Nov 12 (Bernama-GLOBE NEWSWIRE) -- Axi, a global online FX and CFD broker, has joined Babypips as an advertising partner through its Trusted Partner programme, providing an opportunity to increase brand visibility among an established audience of forex traders and those looking to learn more about financial markets.
Founded in 2005, Babypips has become an established online destination for forex education, helping millions of readers understand the foreign exchange market. Its accessible learning resources explain forex trading and the economic forces that influence currency prices and wider financial markets.
Its educational offering includes the School of Pipsology, a structured, self-paced programme with free courses covering forex basics and technical analysis. Its Premium curriculum goes further into price action, macro fundamentals, intermarket analysis, global liquidity and trading plan development, with a strong emphasis on risk management. Babypips also offers market commentary, trading tools, quizzes and a community forum.
Through the Trusted Partner programme, Axi will be featured as an advertising partner on Babypips, giving readers the opportunity to discover more about the broker and its trading services through designated promotional placements. The arrangement provides Axi with access to a relevant audience while allowing Babypips to maintain a distinction between advertising partnerships and its independent educational and editorial content.
“Babypips has built an established presence within the forex education space, reaching an audience interested in understanding and participating in financial markets. Becoming an advertising partner through its Trusted Partner programme gives Axi an opportunity to increase our visibility among this audience and introduce more traders to our offering,” said Julie Sharova, Global Head of Marketing at Axi.
To support traders at every stage, the School of Pipsology has continually evolved beyond introductory forex into advanced market study. Its latest curriculum updates feature specialised modules on price action trading, macro fundamentals, global liquidity, and a practical prop firms 101 guide. Alongside these structured lessons, the platform’s active community forums provide an open space for traders around the world to debate strategy, analyse market movements, and share ideas in real time.
For more information visit www.axi.com and www.babypips.com.
About Axi
Axi is a global online FX and CFD broker, providing thousands of clients across 100+ countries with access to financial markets through intuitive trading platforms, advanced tools, and educational resources. Its product suite includes forex, CFDs, and perpetual futures, with availability varying by region and entity.
About Babypips
Founded in 2005, Babypips is one of the world’s most trusted online resources for retail traders. The platform is best known for its flagship School of Pipsology. Beyond education, Babypips empowers market participants with MarketMilk™, an intuitive visual technical analysis and screening tool, and daily market commentary authored entirely by its veteran in-house editorial team. The team covers forex, equities, commodities like gold and oil, and broader financial markets. Backed by an active global trading community, Babypips equips millions of readers each month with clear, actionable insights to navigate modern investing. For more information, visit www.babypips.com.
Media enquiries: mediaenquiries@axi.com
Promoted by AxiTrader LLC. Trading carries a high risk of investment loss. This content may not be available in your region.
A photo accompanying this announcement is available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/d8460792-6a5d-4a0e-a24b-0058a8ca4b00
SOURCE: Axi Trader LLC
DISCLAIMER: BERNAMA MREM are not accountable for any causes of website defacement, misuse, or illegal activities connected to cryptocurrency, blockchain, tokenisation, or bitcoin. This material should not be considered as guidance or an opinion, as it does not constitute financial or investment advice. Use this information at your own risk; we are not liable for any losses or damages caused by the republication of this article.
--BERNAMA
Wednesday, 11 November 2026
PACIFIC PRIME BAGS FOUR HR VENDOR AWARDS IN SINGAPORE
KUALA LUMPUR, Nov 10 (Bernama) -- Pacific Prime, an international health insurance and employee benefits provider, has won four awards at the HR Vendors of the Year Awards Singapore 2026, including gold for Best HR Compliance Partner.
The company also won silver for Best HR Transformation Partner and two bronze awards for Best HR Management System in the enterprise and small and medium-sized business categories.
“These awards reflect the ambition, commitment and consistency of our Singapore team. We set high standards globally, and I am incredibly proud to see our team continue to raise the bar,” said Pacific Prime Singapore Chief Executive Officer, Heena Bose in a statement.
The awards, hosted by Human Resources Online, were presented at a gala dinner in Singapore on Oct 23. Pacific Prime was represented by Bose, among other members of its leadership.
Pacific Prime said its insurance technology tools were central to the wins. Its Prime Care Portal, which lets human resources (HR) teams manage employee benefits across insurers and markets on a single platform, has served 3,417 corporate clients and 645,028 members to date.
Its Flexible Benefits Portal for employees, which includes benefits selection, e-wallets and a wellness marketplace, processes more than two million claims a year.
Pacific Prime provides insurance technology tools and consulting to help employers manage compliance, employee benefits and corporate risk.
-- BERNAMA
